Tinavi Medical Technologies Co Ltd (688277) - Total Liabilities

Latest as of March 2026: CN¥451.55 Million CNY ≈ $66.08 Million USD

Based on the latest financial reports, Tinavi Medical Technologies Co Ltd (688277) has total liabilities worth CN¥451.55 Million CNY (≈ $66.08 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Tinavi Medical Technologies Co Ltd - Total Liabilities Trend (2013–2025)

This chart illustrates how Tinavi Medical Technologies Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Tinavi Medical Technologies Co Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.

Tinavi Medical Technologies Co Ltd Competitors by Total Liabilities

The table below lists competitors of Tinavi Medical Technologies Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
PLAYTIKA HOLDING DL-01
F:8II
Germany €4.13 Billion
China Security & Fire Co Ltd Class A
SHG:600654
China CN¥1.93 Billion
H&K AG
PA:MLHK
France €347.80 Million
Der International Home Furnishing Co Ltd
SHE:002631
China CN¥1.09 Billion
Lotte Corp
KO:004990
Korea ₩14.16 Trillion
Kale Environmental Technology (Shanghai) Corporation
SHE:301070
China CN¥151.93 Million
Cosmax Inc
KO:192820
Korea ₩1.55 Trillion

Liability Composition Analysis (2013–2025)

This chart breaks down Tinavi Medical Technologies Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Tinavi Medical Technologies Co Ltd stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.83 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.39 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.27 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Tinavi Medical Technologies Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Tinavi Medical Technologies Co Ltd (2013–2025)

The table below shows the annual total liabilities of Tinavi Medical Technologies Co Ltd from 2013 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥-1.29 Billion
≈ $-189.07 Million
-413.93%
2024-12-31 CN¥411.58 Million
≈ $60.23 Million
+7.76%
2023-12-31 CN¥381.95 Million
≈ $55.89 Million
+31.99%
2022-12-31 CN¥289.39 Million
≈ $42.35 Million
+36.84%
2021-12-31 CN¥211.48 Million
≈ $30.95 Million
+128.07%
2020-12-31 CN¥92.73 Million
≈ $13.57 Million
-20.92%
2019-12-31 CN¥117.26 Million
≈ $17.16 Million
+14.91%
2018-12-31 CN¥102.05 Million
≈ $14.93 Million
-77.49%
2017-12-31 CN¥453.26 Million
≈ $66.33 Million
+822.09%
2016-12-31 CN¥49.16 Million
≈ $7.19 Million
+515.93%
2015-12-31 CN¥7.98 Million
≈ $1.17 Million
-43.98%
2014-12-31 CN¥14.25 Million
≈ $2.08 Million
+21.14%
2013-12-31 CN¥11.76 Million
≈ $1.72 Million
--

About Tinavi Medical Technologies Co Ltd

SHG:688277 China Medical Instruments & Supplies
Market Cap
$1.14 Billion
CN¥7.79 Billion CNY
Market Cap Rank
#8421 Global
#2057 in China
Share Price
CN¥17.08
Change (1 day)
-10.72%
52-Week Range
CN¥13.76 - CN¥27.95
All Time High
CN¥141.60
About

Tinavi Medical Technologies Co.,Ltd. engages in the research and development, production, sale, market, service, and clinical application of orthopedic surgery robots and related technologies. The company offers TiRobot II, an orthopedic robotic system to create an operation center; TiRobot, an orthopedic robotic system used in implants in surgery for spine and trauma; 5G remote surgery systems; … Read more